- Report
- August 2023
- 300 Pages
Europe
From €3122EUR$3,430USD£2,676GBP
€4459EUR$4,900USD£3,823GBP
- Report
- August 2023
- 1300 Pages
Global
From €5670EUR$6,230USD£4,861GBP
€8100EUR$8,900USD£6,944GBP
- Report
- August 2023
- 51 Pages
South Korea
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Mexico
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Canada
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Germany
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
France
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
United States
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Australia
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Japan
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Turkey
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Italy
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
China
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Switzerland
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Argentina
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Brazil
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP
- Report
- August 2023
- 51 Pages
Israel
From €382EUR$420USD£328GBP
€546EUR$600USD£468GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more